IGM Biosciences (IGMS) Earnings Date & Reports

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IGMS is expected to report earnings to fall 27.33% to -73 cents per share on March 27

IGM Biosciences IGMS Stock Earnings Reports

Q4'24

Est.

$-0.73

Q3'24

Missed

by $0.21

Q2'24

Missed

by $0.75

Q1'24

Missed

by $0.02

Q4'23

Est.

$-1.01

The last earnings report on November 08 showed earnings per share of -100 cents, missing the estimate of -80 cents. With 136.53K shares outstanding, the current market capitalization sits at 80.10M.

View a ticker or compare two or three

Compare

IGMS